PursueCare Company News

Join us as our CEO and Founder, Nick Mercadante, will highlight innovation, access, and human impact in behavioral health. San Diego, CA—November 5, 2025—PursueCare, a leader in virtual addiction and behavioral health treatment, announced today its sponsorship of the Behavioral Health Tech (BHT) Conference 2025,... (read more)

PursueCare is pleased to announce the promotion of Jason Kirby, DO, MBA, DFASAM to Chief Medical Officer (CMO). Dr. Kirby will lead a focused plan to strengthen clinical practices, outcomes, and programs. He will oversee our Medical Providers, Medical Directors, and Clinical Directors as well... (read more)

MIDDLETOWN, CT—PursueCare, a virtual addiction treatment provider, announced today that it has been named a “Best in Class” Quarterfinalist in the Mental and Behavioral Health category by the Digital Health Hub Foundation, a global community of health tech accelerators dedicated to supporting the growth and scalability... (read more)

We’re excited to announce that Linda Kniebel has joined PursueCare as our new Head of Enterprise Partnerships.  Linda brings 20+ years of healthcare experience spanning specialty pharmaceuticals, medical devices, and digital SaaS solutions. She has led initiatives in complex medication management, pharmacogenomics, remote patient monitoring,... (read more)

Dr. Jason Kirby, DO, MBA, DFASAM is schedule to be a session presenter at OMED25. Be sure to register today to attend his session and explore many others. Dr. Kirby is looking forward to aligning leadership, education, and patient care while connecting with DOs, residents,... (read more)

And How PursueCare Can Help Recently, the FDA has pushed for 7-OH Mitragynine, a high-potency form of Kratom sold in head shops, to be classified as a Schedule I substance. If approved, possession of this substance will become illegal, and many individuals dependent on it... (read more)

Imagine a patient who has just conquered heroin dependence—only to succumb to a cigarette or vaping habit that shatters their lungs, steals decades from their life, and leaves them vulnerable to cancer and heart disease. This scenario is heartbreakingly common. If we ignore tobacco dependence... (read more)

Last week, during my annual checkup, I encountered a familiar part of the process: the health questionnaire. Among the questions, there was one about alcohol and substance use—how often I drink, whether it’s socially or daily, and if I use other substances. It made me... (read more)

In the field of addiction medicine, recovery is not a linear path—it requires consistency, compassion, and a system built around accessibility and trust. At PursueCare, our telehealth-based Medication-Assisted Treatment (MAT) model is uniquely designed to meet patients where they are. But success doesn’t come from... (read more)

CEO Nicholas Mercadante to Share Vision on Transformative SUD Care July 14, 2025   MIDDLETOWN, CT—PursueCare, a virtual clinic for substance use disorder (SUD) treatment, will participate in a panel exploring partnerships and strategies for integrated, whole-person care models in behavioral health at the 2025 Behavioral... (read more)

An article written by Ashleigh Hollowell and published on Behavioral Health Business titled “What a ‘Perfect’ SUD Care Model Would Actually Look Like,” envisions an ideal framework for treating Substance Use Disorder (SUD) by addressing current systemic shortcomings and proposing comprehensive, patient-centered solutions. PursueCare’s Medical... (read more)

The article titled “What SUD Treatment Providers Can Learn from Oncology Care” written by Ashleigh Hollowell and published on Behavioral Health Business explores how strategies from oncology can enhance substance use disorder (SUD) treatment. It emphasizes the importance of structured follow-up care, similar to oncology... (read more)